224 related articles for article (PubMed ID: 32917927)
21. A novel model of controlling PD-L1 expression in ALK
Zhang JP; Song Z; Wang HB; Lang L; Yang YZ; Xiao W; Webster DE; Wei W; Barta SK; Kadin ME; Staudt LM; Nakagawa M; Yang Y
Blood; 2019 Jul; 134(2):171-185. PubMed ID: 31151983
[TBL] [Abstract][Full Text] [Related]
22. Mechanisms of suppression of cell growth by dual inhibition of ALK and MEK in ALK-positive non-small cell lung cancer.
Shrestha N; Nimick M; Dass P; Rosengren RJ; Ashton JC
Sci Rep; 2019 Dec; 9(1):18842. PubMed ID: 31827192
[TBL] [Abstract][Full Text] [Related]
23. Anaplastic Lymphoma Kinase (ALK) Receptor Tyrosine Kinase: A Catalytic Receptor with Many Faces.
Huang H
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400214
[TBL] [Abstract][Full Text] [Related]
24. Jelly belly protein activates the receptor tyrosine kinase Alk to specify visceral muscle pioneers.
Lee HH; Norris A; Weiss JB; Frasch M
Nature; 2003 Oct; 425(6957):507-12. PubMed ID: 14523446
[TBL] [Abstract][Full Text] [Related]
25. Restraint of presynaptic protein levels by Wnd/DLK signaling mediates synaptic defects associated with the kinesin-3 motor Unc-104.
Li J; Zhang YV; Asghari Adib E; Stanchev DT; Xiong X; Klinedinst S; Soppina P; Jahn TR; Hume RI; Rasse TM; Collins CA
Elife; 2017 Sep; 6():. PubMed ID: 28925357
[TBL] [Abstract][Full Text] [Related]
26. Targeted disruption of dual leucine zipper kinase and leucine zipper kinase promotes neuronal survival in a model of diffuse traumatic brain injury.
Welsbie DS; Ziogas NK; Xu L; Kim BJ; Ge Y; Patel AK; Ryu J; Lehar M; Alexandris AS; Stewart N; Zack DJ; Koliatsos VE
Mol Neurodegener; 2019 Nov; 14(1):44. PubMed ID: 31775817
[TBL] [Abstract][Full Text] [Related]
27. The neuronal receptor tyrosine kinase Alk is a target for longevity.
Woodling NS; Aleyakpo B; Dyson MC; Minkley LJ; Rajasingam A; Dobson AJ; Leung KHC; Pomposova S; Fuentealba M; Alic N; Partridge L
Aging Cell; 2020 May; 19(5):e13137. PubMed ID: 32291952
[TBL] [Abstract][Full Text] [Related]
28. A kinome-wide RNAi screen identifies ALK as a target to sensitize neuroblastoma cells for HDAC8-inhibitor treatment.
Shen J; Najafi S; Stäble S; Fabian J; Koeneke E; Kolbinger FR; Wrobel JK; Meder B; Distel M; Heimburg T; Sippl W; Jung M; Peterziel H; Kranz D; Boutros M; Westermann F; Witt O; Oehme I
Cell Death Differ; 2018 Dec; 25(12):2053-2070. PubMed ID: 29515255
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
Merkel O; Hamacher F; Griessl R; Grabner L; Schiefer AI; Prutsch N; Baer C; Egger G; Schlederer M; Krenn PW; Hartmann TN; Simonitsch-Klupp I; Plass C; Staber PB; Moriggl R; Turner SD; Greil R; Kenner L
J Pathol; 2015 Aug; 236(4):445-56. PubMed ID: 25820993
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of DAlk: a novel Drosophila melanogaster RTK which drives ERK activation in vivo.
Lorén CE; Scully A; Grabbe C; Edeen PT; Thomas J; McKeown M; Hunter T; Palmer RH
Genes Cells; 2001 Jun; 6(6):531-44. PubMed ID: 11442633
[TBL] [Abstract][Full Text] [Related]
31. Reaper-mediated inhibition of DIAP1-induced DTRAF1 degradation results in activation of JNK in Drosophila.
Kuranaga E; Kanuka H; Igaki T; Sawamoto K; Ichijo H; Okano H; Miura M
Nat Cell Biol; 2002 Sep; 4(9):705-10. PubMed ID: 12198495
[TBL] [Abstract][Full Text] [Related]
32. A conditioning lesion protects axons from degeneration via the Wallenda/DLK MAP kinase signaling cascade.
Xiong X; Collins CA
J Neurosci; 2012 Jan; 32(2):610-5. PubMed ID: 22238096
[TBL] [Abstract][Full Text] [Related]
33. Patient-associated mutations in Drosophila Alk perturb neuronal differentiation and promote survival.
Pfeifer K; Wolfstetter G; Anthonydhason V; Masudi T; Arefin B; Bemark M; Mendoza-Garcia P; Palmer RH
Dis Model Mech; 2022 Aug; 15(8):. PubMed ID: 35972154
[TBL] [Abstract][Full Text] [Related]
34. Bimodal control of dendritic and axonal growth by the dual leucine zipper kinase pathway.
Wang X; Kim JH; Bazzi M; Robinson S; Collins CA; Ye B
PLoS Biol; 2013; 11(6):e1001572. PubMed ID: 23750116
[TBL] [Abstract][Full Text] [Related]
35. Structural basis for ligand reception by anaplastic lymphoma kinase.
Li T; Stayrook SE; Tsutsui Y; Zhang J; Wang Y; Li H; Proffitt A; Krimmer SG; Ahmed M; Belliveau O; Walker IX; Mudumbi KC; Suzuki Y; Lax I; Alvarado D; Lemmon MA; Schlessinger J; Klein DE
Nature; 2021 Dec; 600(7887):148-152. PubMed ID: 34819665
[TBL] [Abstract][Full Text] [Related]
36. Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.
He D; Lasek AW
Mol Pharmacol; 2020 Feb; 97(2):123-131. PubMed ID: 31734646
[TBL] [Abstract][Full Text] [Related]
37. Mapping the Phospho-dependent ALK Interactome to Identify Novel Components in ALK Signaling.
Aboualizadeh F; Yao Z; Guan J; Drecun L; Pathmanathan S; Snider J; Umapathy G; Kotlyar M; Jurisica I; Palmer R; Stagljar I
J Mol Biol; 2021 Nov; 433(23):167283. PubMed ID: 34606829
[TBL] [Abstract][Full Text] [Related]
38. Multitasking: Dual Leucine Zipper-Bearing Kinases in Neuronal Development and Stress Management.
Jin Y; Zheng B
Annu Rev Cell Dev Biol; 2019 Oct; 35():501-521. PubMed ID: 31590586
[TBL] [Abstract][Full Text] [Related]
39. miR-497 suppresses cycle progression through an axis involving CDK6 in ALK-positive cells.
Hoareau-Aveilla C; Quelen C; Congras A; Caillet N; Labourdette D; Dozier C; Brousset P; Lamant L; Meggetto F
Haematologica; 2019 Feb; 104(2):347-359. PubMed ID: 30262555
[TBL] [Abstract][Full Text] [Related]
40. Two different specific JNK activators are required to trigger apoptosis or compensatory proliferation in response to Rbf1 in Drosophila.
Clavier A; Rincheval-Arnold A; Baillet A; Mignotte B; Guénal I
Cell Cycle; 2016; 15(2):283-94. PubMed ID: 26825229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
